Holen Sie sich die Stockscreener-App
21.09
6.39%
-1.44
Handel nachbörslich:
21.09
Schlusskurs vom Vortag:
$22.53
Offen:
$22.51
24-Stunden-Volumen:
537.18K
Relative Volume:
1.02
Marktkapitalisierung:
$590.46M
Einnahmen:
$17.16M
Nettoeinkommen (Verlust:
$-163.62M
KGV:
-3.4688
EPS:
-6.08
Netto-Cashflow:
$-121.61M
1W Leistung:
+4.77%
1M Leistung:
-12.96%
6M Leistung:
+38.30%
1J Leistung:
-43.20%
1-Tages-Spanne:
$20.82
$22.98
1-Wochen-Bereich:
$19.86
$22.98
52-Wochen-Spanne:
$12.21
$40.70
Anaptysbio Inc Stock (ANAB) Company Profile
Firmenname
Anaptysbio Inc
Sektor
Branche
Telefon
858-362-6295
Adresse
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Vergleichen Sie ANAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ANAB
Anaptysbio Inc
|
21.09 | 576.52M | 17.16M | -163.62M | -121.61M | -6.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2024-12-11 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-12-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-07-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-04-16 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-11 | Eingeleitet | Wells Fargo | Overweight |
| 2024-03-12 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | BTIG Research | Buy |
| 2024-02-21 | Eingeleitet | Stifel | Buy |
| 2024-02-16 | Eingeleitet | Piper Sandler | Overweight |
| 2023-05-22 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2023-05-18 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-13 | Herabstufung | Truist | Buy → Hold |
| 2022-09-01 | Eingeleitet | Raymond James | Outperform |
| 2022-03-22 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-21 | Eingeleitet | UBS | Neutral |
| 2021-03-16 | Hochstufung | Truist | Hold → Buy |
| 2021-03-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2021-03-08 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2021-02-11 | Hochstufung | JP Morgan | Underweight → Overweight |
| 2020-10-27 | Hochstufung | Wedbush | Neutral → Outperform |
| 2020-10-14 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-11-08 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2019-11-08 | Herabstufung | Jefferies | Buy → Hold |
| 2019-11-08 | Herabstufung | SunTrust | Buy → Hold |
| 2019-11-08 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-06-21 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | Herabstufung | Stifel | Buy → Hold |
| 2018-12-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-11-21 | Eingeleitet | JP Morgan | Overweight |
| 2018-07-19 | Eingeleitet | Credit Suisse | Outperform |
| 2018-04-04 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | Bestätigt | Stifel | Buy |
| 2018-03-06 | Bestätigt | Stifel | Buy |
| 2018-02-15 | Bestätigt | SunTrust | Buy |
| 2018-01-23 | Bestätigt | Credit Suisse | Outperform |
| 2017-11-15 | Eingeleitet | SunTrust | Buy |
| 2017-11-09 | Eingeleitet | Jefferies | Buy |
| 2017-10-11 | Bestätigt | RBC Capital Mkts | Outperform |
| 2017-09-15 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Anaptysbio Inc Aktie (ANAB) Neueste Nachrichten
Visualizing AnaptysBio Inc. stock with heatmaps2025 Fundamental Recap & AI Driven Stock Reports - Newser
AnaptysBio, Inc. $ANAB Position Trimmed by Charles Schwab Investment Management Inc. - MarketBeat
683 Capital Management LLC Makes New $3.64 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat
What machine learning models say about AnaptysBio Inc.2025 Stock Rankings & Free Verified High Yield Trade Plans - Newser
First Light Asset Management LLC Raises Stock Holdings in AnaptysBio, Inc. $ANAB - MarketBeat
How to recover losses in AnaptysBio Inc. stock2025 Winners & Losers & Verified Technical Signals - Newser
Is AnaptysBio Inc. trading at a discount2025 Trading Volume Trends & Trade Opportunity Analysis Reports - khodrobank.com
Will AnaptysBio Inc. outperform its industry peersJuly 2025 Spike Watch & Daily Technical Stock Forecast Reports - khodrobank.com
Can swing trading help recover from AnaptysBio Inc. lossesJuly 2025 Catalysts & Safe Capital Investment Plans - Newser
Using Ichimoku Cloud for AnaptysBio Inc. technicalsMarket Trend Report & Free Real-Time Volume Trigger Notifications - Newser
Technical signs of recovery in AnaptysBio Inc.Earnings Growth Summary & Safe Capital Growth Plans - Newser
Will AnaptysBio Inc. price bounce be sustainableJuly 2025 Levels & Real-Time Stock Movement Alerts - Newser
Nuveen LLC Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat
AnaptysBio Inc.’s volatility index tracking explainedDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Can trapped investors hope for a rebound in AnaptysBio Inc.2025 Fundamental Recap & Fast Gain Swing Trade Alerts - Newser
Can momentum traders help lift AnaptysBio Inc.July 2025 Opening Moves & Stock Market Timing Techniques - Newser
Can AnaptysBio Inc. ride the EV waveMarket Sentiment Review & Real-Time Volume Spike Alerts - khodrobank.com
Chart based analysis of AnaptysBio Inc. trends2025 Bull vs Bear & Verified Entry Point Signals - Newser
Is AnaptysBio Inc. a cyclical or defensive stockJuly 2025 Technicals & Fast Entry and Exit Trade Plans - khodrobank.com
Historical volatility pattern of AnaptysBio Inc. visualizedJuly 2025 Recap & Expert Approved Momentum Trade Ideas - Newser
Will AnaptysBio Inc. continue its uptrendSwing Trade & Free Reliable Trade Execution Plans - Newser
What does recent volatility data suggest for AnaptysBio Inc.Wall Street Watch & Intraday High Probability Alerts - Newser
Will AnaptysBio Inc. benefit from geopolitical trendsWeekly Stock Recap & Verified Swing Trading Watchlists - khodrobank.com
Vanguard Group Inc. Trims Stock Position in AnaptysBio, Inc. $ANAB - MarketBeat
How cyclical is AnaptysBio Inc.’s revenue streamPortfolio Risk Report & Weekly Setup with High ROI Potential - خودرو بانک
Investment Review: Will AnaptysBio Inc. outperform tech stocksEarnings Growth Summary & AI Driven Stock Reports - khodrobank.com
Downgrade Watch: Will AnaptysBio Inc. outperform its industry peers2025 Volume Leaders & Safe Capital Growth Stock Tips - خودرو بانک
AnaptysBio Inc. stock momentum explainedJuly 2025 Selloffs & Free AI Powered Buy and Sell Recommendations - Newser
Strategies to average down on AnaptysBio Inc.2025 Fundamental Recap & Smart Allocation Stock Tips - Newser
What recovery options are there for AnaptysBio Inc.M&A Rumor & Safe Entry Trade Reports - Newser
Bollinger Bands Expand on AnaptysBio Inc. — Volatility Ahead getLinesFromResByArray error: size == 0 - thegnnews.com
Cresset Asset Management LLC Makes New $272,000 Investment in AnaptysBio, Inc. $ANAB - MarketBeat
Trend analysis for AnaptysBio Inc. this weekJuly 2025 Market Mood & Low Drawdown Investment Strategies - Newser
How to use a screener to detect AnaptysBio Inc. breakoutsTrade Volume Report & Real-Time Volume Trigger Notifications - Newser
Will a bounce in AnaptysBio Inc. offer an exit2025 Earnings Surprises & Verified Entry Point Signals - Newser
Statistical indicators supporting AnaptysBio Inc.’s strength2025 AllTime Highs & High Accuracy Swing Trade Signals - Newser
Earnings visualization tools for AnaptysBio Inc.July 2025 Analyst Calls & Low Risk High Reward Ideas - Newser
Building trade automation scripts for AnaptysBio Inc.2025 Price Targets & Weekly High Return Opportunities - Newser
AnaptysBio Inc. stock trend forecastPortfolio Gains Summary & Breakout Confirmation Alerts - Newser
Will earnings trigger a reversal in AnaptysBio Inc.July 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Will AnaptysBio Inc. rebound enough to break evenInsider Selling & High Yield Stock Recommendations - Newser
Finanzdaten der Anaptysbio Inc-Aktie (ANAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Anaptysbio Inc-Aktie (ANAB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| RENTON HOLLINGS | Director |
Aug 08 '25 |
Sale |
19.62 |
10,231 |
200,714 |
4,965 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):